These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 9300407)

  • 1. Riluzole protects from motor deficits and striatal degeneration produced by systemic 3-nitropropionic acid intoxication in rats.
    Guyot MC; Palfi S; Stutzmann JM; Mazière M; Hantraye P; Brouillet E
    Neuroscience; 1997 Nov; 81(1):141-9. PubMed ID: 9300407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Major strain differences in response to chronic systemic administration of the mitochondrial toxin 3-nitropropionic acid in rats: implications for neuroprotection studies.
    Ouary S; Bizat N; Altairac S; Ménétrat H; Mittoux V; Condé F; Hantraye P; Brouillet E
    Neuroscience; 2000; 97(3):521-30. PubMed ID: 10828534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of alpha-phenyl-tert-butyl nitrone on neuronal survival and motor function following intrastriatal injections of quinolinate or 3-nitropropionic acid.
    Nakao N; Brundin P
    Neuroscience; 1997 Feb; 76(3):749-61. PubMed ID: 9135048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantifiable bradykinesia, gait abnormalities and Huntington's disease-like striatal lesions in rats chronically treated with 3-nitropropionic acid.
    Guyot MC; Hantraye P; Dolan R; Palfi S; Maziére M; Brouillet E
    Neuroscience; 1997 Jul; 79(1):45-56. PubMed ID: 9178864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Riluzole reduces incidence of abnormal movements but not striatal cell death in a primate model of progressive striatal degeneration.
    Palfi S; Riche D; Brouillet E; Guyot MC; Mary V; Wahl F; Peschanski M; Stutzmann JM; Hantraye P
    Exp Neurol; 1997 Jul; 146(1):135-41. PubMed ID: 9225746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Partial inhibition of brain succinate dehydrogenase by 3-nitropropionic acid is sufficient to initiate striatal degeneration in rat.
    Brouillet E; Guyot MC; Mittoux V; Altairac S; Condé F; Palfi S; Hantraye P
    J Neurochem; 1998 Feb; 70(2):794-805. PubMed ID: 9453576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of resveratrol on 3-nitropropionic acid-induced biochemical and behavioural changes: possible neuroprotective mechanisms.
    Kumar P; Padi SS; Naidu PS; Kumar A
    Behav Pharmacol; 2006 Sep; 17(5-6):485-92. PubMed ID: 16940769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glial cell line-derived neurotrophic factor attenuates the locomotor hypofunction and striatonigral neurochemical deficits induced by chronic systemic administration of the mitochondrial toxin 3-nitropropionic acid.
    Araujo DM; Hilt DC
    Neuroscience; 1998 Jan; 82(1):117-27. PubMed ID: 9483508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Melatonin reduces projection neuronal injury induced by 3-nitropropionic acid in the rat striatum.
    Mu S; Lin E; Liu B; Ma Y; OuYang L; Li Y; Chen S; Zhang J; Lei W
    Neurodegener Dis; 2014; 14(3):139-50. PubMed ID: 25342207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral Dyskinesias and striatal lesions in rats after long-term co-treatment with haloperidol and 3-nitropropionic acid.
    Andreassen OA; Ferrante RJ; Beal MF; Jørgensen HA
    Neuroscience; 1998 Dec; 87(3):639-48. PubMed ID: 9758230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression and distribution of redox regulatory protein, thioredoxin after metabolic impairment by 3-nitropropionic acid in rat brain.
    Sugino T; Nozaki K; Takagi Y; Hattori I; Hashimoto N; Yodoi J
    Neurosci Lett; 1999 Nov; 275(2):145-8. PubMed ID: 10568520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subacute systemic 3-nitropropionic acid intoxication induces a distinct motor disorder in adult C57Bl/6 mice: behavioural and histopathological characterisation.
    Fernagut PO; Diguet E; Stefanova N; Biran M; Wenning GK; Canioni P; Bioulac B; Tison F
    Neuroscience; 2002; 114(4):1005-17. PubMed ID: 12379255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutant SOD1G93A in bone marrow-derived cells exacerbates 3-nitropropionic acid induced striatal damage in mice.
    Huang QY; Yu L; Ferrante RJ; Chen JF
    Neurosci Lett; 2007 May; 418(2):175-80. PubMed ID: 17418947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estrogen protects against while testosterone exacerbates vulnerability of the lateral striatal artery to chemical hypoxia by 3-nitropropionic acid.
    Nishino H; Nakajima K; Kumazaki M; Fukuda A; Muramatsu K; Deshpande SB; Inubushi T; Morikawa S; Borlongan CV; Sanberg PR
    Neurosci Res; 1998 Apr; 30(4):303-12. PubMed ID: 9678634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 3-Nitropropionic acid exacerbates N-methyl-D-aspartate toxicity in striatal culture by multiple mechanisms.
    Greene JG; Sheu SS; Gross RA; Greenamyre JT
    Neuroscience; 1998 May; 84(2):503-10. PubMed ID: 9539220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid.
    Beal MF; Brouillet E; Jenkins BG; Ferrante RJ; Kowall NW; Miller JM; Storey E; Srivastava R; Rosen BR; Hyman BT
    J Neurosci; 1993 Oct; 13(10):4181-92. PubMed ID: 7692009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential responsiveness of rat striatal nerve endings to the mitochondrial toxin 3-nitropropionic acid: implications for Huntington's disease.
    Marti M; Mela F; Ulazzi L; Hanau S; Stocchi S; Paganini F; Beani L; Bianchi C; Morari M
    Eur J Neurosci; 2003 Aug; 18(4):759-67. PubMed ID: 12925002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clorgyline and deprenyl attenuate striatal malonate and 3-nitropropionic acid lesions.
    Maragos WF; Tillman PA; Chesnut MD; Jakel RJ
    Brain Res; 1999 Jul; 834(1-2):168-72. PubMed ID: 10407109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of intrastriatal injections of quinolinic acid and 3-nitropropionic acid for use in animal models of Huntington's disease.
    Shear DA; Dong J; Gundy CD; Haik-Creguer KL; Dunbar GL
    Prog Neuropsychopharmacol Biol Psychiatry; 1998 Oct; 22(7):1217-40. PubMed ID: 9829299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The adenosine A1 receptor agonist adenosine amine congener exerts a neuroprotective effect against the development of striatal lesions and motor impairments in the 3-nitropropionic acid model of neurotoxicity.
    Blum D; Gall D; Galas MC; d'Alcantara P; Bantubungi K; Schiffmann SN
    J Neurosci; 2002 Oct; 22(20):9122-33. PubMed ID: 12388620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.